Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8477)
All Articles published online
|
Publishing Process of This Article
|
May 28, 2015 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Liao XM, Nong GH, Chen MZ, Huang XP, Cong YY, Huang YY, Wu BH, Wei JQ. Modified sequential therapy |
|---|---|
| URL: | https://www.wjgnet.com/2150-5330/full/v21/i20/6310.htm |
| Number | Citing Articles |
| 1 |
Huimei Xu, Wancong Wang, Xueni Ma, Rukun Feng, Yujing Su, Long Cheng, Yifan Yang, Dekui Zhang. Comparative efficacy and safety of high-dose dual therapy, bismuth-based quadruple therapy and non-bismuth quadruple therapies for Helicobacter pylori infection: a network meta-analysis. European Journal of Gastroenterology & Hepatology 2021; 33(6): 775 doi: 10.1097/MEG.0000000000001835
|
| 2 |
Hassan Seddik, Jihane Benass, Sanaa Berrag, Asmae Sair, Reda Berraida, Hanae Boutallaka. Optimized sequential therapy <i>vs</i> 10- and 14-d concomitant therapy for eradicating <i>Helicobacter pylori</i>: A randomized clinical trial. World Journal of Gastroenterology 2024; 30(6): 556-564 doi: 10.3748/wjg.v30.i6.556
Abstract(338) |
Core Tip(333) |
Full Article(HTML)(2304)
|
Full Article with Cover (PDF)-735K(139)
|
Full Article (Word)-201K(12)
|
Audio-940K(7)
|
Peer-Review Report-206K(48)
|
Answering Reviewers-124K(53)
|
Full Article (PDF)-484K(141)
|
Full Article (XML)-99K(42)
|
Times Cited (0)
|
Total Visits (5304)
|
Open
|
| 3 |
Amin Talebi Bezmin Abadi. Helicobacter pylori treatment: New perspectives using current experience. Journal of Global Antimicrobial Resistance 2017; 8: 123 doi: 10.1016/j.jgar.2016.11.008
|
| 4 |
Jing Li, Huiying Shi, Fang Zhou, Li Xie, Rong Lin. The Efficacy and Safety of Regimens for Helicobacter pylori Eradication Treatment in China. Journal of Clinical Gastroenterology 2024; 58(1): 12 doi: 10.1097/MCG.0000000000001902
|
| 5 |
Jianping Cheng, Chanjuan Fan, Zhen Li, Zhaojing Dong, Xiaolin Zhao, Yong Cai, Haiou Ding, Yan Dou, Xiaomei Zhang. Real-World Situation of Eradication Regimens and Risk Factors for Helicobacter pylori Treatment in China: A Retrospective Single-Center Study. Clinical and Experimental Gastroenterology 2024; : 191 doi: 10.2147/CEG.S466975
|
| 6 |
Seung Woo Lee, Sung Jin Moon, Sae Hee Kim, Sung Hee Jung, Kyung Ho Song, Sun Moon Kim, Jae Kyu Sung, Dong Soo Lee. The prolongation effect of ilaprazole-based standard triple therapy for Helicobacter pylori. Medicine 2020; 99(38): e22137 doi: 10.1097/MD.0000000000022137
|
| 7 |
Jinhao Jia, Huijie Zhao, Fangfei Li, Qiusheng Zheng, Guoli Wang, Defang Li, Ying Liu. Research on drug treatment and the novel signaling pathway of chronic atrophic gastritis. Biomedicine & Pharmacotherapy 2024; 176: 116912 doi: 10.1016/j.biopha.2024.116912
|
| 8 |
Guiqiu Zhang, Kaijing Guo, Pengfei Wang, Yingbo Shan, Chen Ma. Identification of the New In Vivo Metabolites of Ilaprazole in Rat Plasma after Oral Administration by LC-MS: In Silico Prediction of the H+/K+-ATPase Inhibitor. Molecules 2021; 26(2): 459 doi: 10.3390/molecules26020459
|
| 9 |
Salma Souissi, Cyrine Makni, Basma Chaieb, Amine Jarraya, Nadia Toulgui, Lobna Jmal, Mouna Mlika, Chadlia Fendri, Mohamed Bouchoucha, Rabie Razgallah, Leila Belhadj Ammar, Olfa Bousnina, Fawzi Mezni, Awatef Jmal, Lamia Kallel.
Eradication of
Helicobacter pylori
: a prospective comparative randomized trial of standard versus optimized quadruple therapy
. Future Science OA 2024; 10(1) doi: 10.2144/fsoa-2023-0316
|